Literature DB >> 17532006

Crystal structure of an asymmetric complex of pyruvate dehydrogenase kinase 3 with lipoyl domain 2 and its biological implications.

Yancho Devedjiev1, C Nicklaus Steussy, Dmitry G Vassylyev.   

Abstract

A homodimer of pyruvate dehydrogenase kinase (PDHK) is an integral part of pyruvate dehydrogenase complex (PDC) to which it is anchored primarily through the inner lipoyl-bearing domains (L2) of transacetylase component. The catalytic cycle of PDHK and its translocation over the PDC surface is thought to be mediated by the "symmetric" and "asymmetric" modes, in which the PDHK dimer binds to two and one L2-domain(s), respectively. Whereas the structure of the symmetric PDHK/L2 complex was reported, the structural organization and functional role of the asymmetric complex remain obscure. Here, we report the crystal structure of the asymmetric PDHK3/L2 complex that reveals several functionally important features absent from the previous structures. First, the PDHK3 subunits have distinct conformations: one subunit exhibits "open" and the other "closed" configuration of the putative substrate-binding cleft. Second, access to the closed cleft is additionally restricted by local unwinding of the adjacent alpha-helix. Modeling indicates that the target peptide might gain access to the PDHK active center through the open but not through the closed cleft. Third, the ATP-binding loop in one PDHK3 subunit adopts an open conformation, implying that the nucleotide loading into the active site is mediated by the inactive "pre-insertion" binding mode. Altogether our data suggest that the asymmetric complex represents a physiological state in which binding of a single L2-domain activates one of the PDHK protomers while inactivating another. Thus, the L2-domains likely act not only as the structural anchors but also modulate the catalytic cycle of PDHK.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532006      PMCID: PMC1994203          DOI: 10.1016/j.jmb.2007.04.083

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex.

Authors:  Alina Tuganova; Igor Boulatnikov; Kirill M Popov
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

2.  Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase.

Authors:  C N Steussy; K M Popov; M M Bowker-Kinley; R B Sloan; R A Harris; J A Hamilton
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

3.  Implementation of molecular replacement in AMoRe.

Authors:  J Navaza
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-09-21

4.  Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 A resolution.

Authors:  Dmitry G Vassylyev; Shun-ichi Sekine; Oleg Laptenko; Jookyung Lee; Marina N Vassylyeva; Sergei Borukhov; Shigeyuki Yokoyama
Journal:  Nature       Date:  2002-05-08       Impact factor: 49.962

Review 5.  Essential roles of lipoyl domains in the activated function and control of pyruvate dehydrogenase kinases and phosphatase isoform 1.

Authors:  Thomas E Roche; Yasuaki Hiromasa; Ali Turkan; Xiaoming Gong; Tao Peng; Xiaohua Yan; Shane A Kasten; Haiying Bao; Jianchun Dong
Journal:  Eur J Biochem       Date:  2003-03

6.  Structural basis for substrate selection by t7 RNA polymerase.

Authors:  Dmitry Temiakov; Vsevolod Patlan; Michael Anikin; William T McAllister; Shigeyuki Yokoyama; Dmitry G Vassylyev
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

7.  Role of protein-protein interactions in the regulation of pyruvate dehydrogenase kinase activity.

Authors:  Alina Tuganova; Kirill M Popov
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

8.  Evidence that pyruvate dehydrogenase kinase belongs to the ATPase/kinase superfamily.

Authors:  M Bowker-Kinley; K M Popov
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

9.  Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.

Authors:  Masato Kato; Jacinta L Chuang; Shih-Chia Tso; R Max Wynn; David T Chuang
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

10.  ATP binding by glutamyl-tRNA synthetase is switched to the productive mode by tRNA binding.

Authors:  Shun-Ichi Sekine; Osamu Nureki; Daniel Y Dubois; Stéphane Bernier; Robert Chênevert; Jacques Lapointe; Dmitry G Vassylyev; Shigeyuki Yokoyama
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

View more
  11 in total

Review 1.  The pyruvate dehydrogenase complexes: structure-based function and regulation.

Authors:  Mulchand S Patel; Natalia S Nemeria; William Furey; Frank Jordan
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

2.  A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene.

Authors:  Marina L Kennerson; Eppie M Yiu; David T Chuang; Aditi Kidambi; Shih-Chia Tso; Carolyn Ly; Rabia Chaudhry; Alexander P Drew; Gary Rance; Martin B Delatycki; Stephan Züchner; Monique M Ryan; Garth A Nicholson
Journal:  Hum Mol Genet       Date:  2013-01-07       Impact factor: 6.150

3.  Crystal structure of pyruvate dehydrogenase phosphatase 1 and its functional implications.

Authors:  Dmitry G Vassylyev; Jindrich Symersky
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

4.  Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.

Authors:  Masato Kato; Jun Li; Jacinta L Chuang; David T Chuang
Journal:  Structure       Date:  2007-08-02       Impact factor: 5.006

Review 5.  Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?

Authors:  Wen Zhang; Shao-Lin Zhang; Xiaohui Hu; Kin Yip Tam
Journal:  Int J Biol Sci       Date:  2015-11-01       Impact factor: 6.580

6.  Elucidation of the interaction loci of the human pyruvate dehydrogenase complex E2·E3BP core with pyruvate dehydrogenase kinase 1 and kinase 2 by H/D exchange mass spectrometry and nuclear magnetic resonance.

Authors:  Junjie Wang; Sowmini Kumaran; Jieyu Zhou; Natalia S Nemeria; Hu Tao; Lazaros Kakalis; Yun-Hee Park; Barbara Birkaya; Mulchand S Patel; Frank Jordan
Journal:  Biochemistry       Date:  2014-12-17       Impact factor: 3.162

7.  Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.

Authors:  Mariana Galvão Ferrarini; Lindice Mitie Nisimura; Richard Marcel Bruno Moreira Girard; Mayke Bezerra Alencar; Mariana Sayuri Ishikawa Fragoso; Carlla Assis Araújo-Silva; Alan de Almeida Veiga; Ana Paula Ressetti Abud; Sheila Cristina Nardelli; Rossiane C Vommaro; Ariel Mariano Silber; Marie France-Sagot; Andréa Rodrigues Ávila
Journal:  mSphere       Date:  2021-01-06       Impact factor: 4.389

Review 8.  Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer.

Authors:  Youchaou Mobet; Xiaoyi Liu; Tao Liu; Jianhua Yu; Ping Yi
Journal:  Front Cell Dev Biol       Date:  2022-02-03

Review 9.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

Review 10.  Unstructured regions of large enzymatic complexes control the availability of metabolites with signaling functions.

Authors:  Ioannis Skalidis; Christian Tüting; Panagiotis L Kastritis
Journal:  Cell Commun Signal       Date:  2020-08-26       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.